Latest Breaking News On - Rashid sayyid - Page 2 : comparemela.com

ASCO 2024:A Multi-Institution Analysis of Outcomes With First-Line Systemic Therapy for 102 Patients With Metastatic Chromophobe Renal Cell Carcinoma

metastatic chromophobe RCC patients receiving 1st line systemic therapy, first-line systemic therapy for metastatic chromophobe renal cell carcinoma (RCC).

United statesNew yorkJohns hopkinsSahil doshiUniversity of torontoAmerican society of clinical oncologySociety of urologic oncologyClinical oncologyAnnual meetingHematology fellowMemorial sloan kettering cancer centerRashid sayyidUrologic oncologyClinical fellow

ASCO 2024: Advanced Sequencing and Targeted Therapy Strategies in Renal Cell Carcinoma: How Can We Help More Patients Not at the Expense of Toxicity?

ASCO 2024 diagnostic and therapeutic strategies in renal cell carcinoma (RCC), vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs).

San diegoUnited statesUnited kingdomBelzutifan weliregYu wei chenLaurence albigesDepartment of medicineSociety of urologic oncologyUniversity of californiaAmerican society of clinical oncologyUniversity of torontoSan diego medical centerNational cancer databaseClinical oncologyAnnual meetingHypoxia inducible factor

ASCO 2024: Avelumab as Neoadjuvant Therapy in Patients with Muscle-Invasive Urothelial Carcinoma: Survival Data of AURA Trial, Oncodistinct 004

ASCO 2024, Muscle-Invasive Urothelial Carcinoma, Muscle invasive bladder cancer (MIBC), Avelumab, Avelumab as Neoadjuvant Therapy, AURA Trial, Oncodistinct 004.

Bruxelles capitaleUnited statesInstitut jules bordetJeremy blancUniversity of torontoSociety of urologic oncologyAmerican society of clinical oncologyClinical oncologyAnnual meetingUniversitaire de bruxellesLibre de bruxellesRashid sayyidUrologic oncologyClinical fellowNeoadjuvant therapy before radical cystectomy

APCCC 2024: Dosing of Radioligand Therapy in Special Situations And/or Toxicity

APCCC 2024: Dosing of Radioligand Therapy in Special Situations And/or Toxicity
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

New south walesLouise emmettGbq luUniversity of torontoSociety of urologic oncologyUniversity of new south walesProstate cancer consensus conferenceRashid sayyidUrologic oncologyClinical fellowDiffuse bone marrow involvementMulticenter retrospectiveCompromised baseline kidney

APCCC 2024: Ideal Monitoring of Patients with mHSPC – What Is Recommended in Daily Clinical Practice?

APCCC 2024: Ideal Monitoring of Patients with mHSPC – What Is Recommended in Daily Clinical Practice?
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMemorial sloan kettering cancer centerMichael morrisSociety of urologic oncologyProstate cancer working groupUniversity of torontoInternational multicenter studyDivision of solid tumor oncologyProstate cancer consensus conferenceResponse evaluation usingMetastatic castration resistant prostate cancerMedical oncologistClinical directorGenitourinary medical oncology serviceProstate cancer section head